Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
International Cancer Conference Journal|June 1, 2019
Novel combination chemotherapy with radiotherapy for prostate squamous cell carcinomaMitsutaka Onoda, Ryo Sugimoto, Noriyuki Uesugi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 2, 2023
Association between nocturnal polyuria and 24-h blood pressure fluctuations in males with lower urinary tract symptoms: A multicenter prospective studyYoichiro Kato, Hidenori Akaihata, Kentaro Takezawa, et al.
Cancer Science|May 13, 2017
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancerWataru Obara, Fuminori Sato, Kazuyoshi Takeda, et al.
IJU Case Reports|March 5, 2024
A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysisEi Shiomi, Yuta Goto, Mizuki Hisano, et al.
International Journal of Clinical Oncology|January 8, 2020
Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practiceDaichi Tamura, Noriaki Jinnouchi, Masakazu Abe, et al.
Translational Oncology|October 31, 2020
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancerRenpei Kato, Noriaki Jinnouchi, Takashi Tuyukubo, et al.
Frontiers in Oncology|November 29, 2023
Metastatic bladder cancer forming a sigmoidorectal fistula after enfortumab vedotin therapy: a case reportShinji Tamada, Daiki Ikarashi, Naoki Yanagawa, et al.
International Journal of Clinical and Experimental Pathology|January 15, 2020
Sarcomatoid change associated with epithelial-mesenchymal transition in mucinous tubular and spindle cell carcinoma of the kidney: a case reportRyo Sugimoto, Noriyuki Uesugi, Noriyuki Yamada, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 13, 2023
Abnormal carnitine metabolism in hemodialysis patients on different anticoagulantsKie Sekiguchi, Takaya Abe, Ei Shiomi, et al.
Translational Oncology|May 7, 2020
Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical SettingRenpei Kato, Daiki Ikarashi, Tomohiko Matsuura, et al.
Pageof 7